Highest-materiality recent filing
Silicon Labs and Texas Instruments: HSR waiting period expires, deal moves forward
HSR Act waiting period expired May 22, 2026, satisfying one condition to close merger with Texas Instruments.
Silicon Labs Q1 revenue $214M (+20% YoY); non-GAAP EPS $0.53; guidance suspended due to TI merger
Revenue $214M, up 20% YoY; Industrial & Commercial up 33% to $128M, Home & Life up 5% to $86M.
Silicon Labs shareholders approve merger with Texas Instruments
Over 99.9% of votes cast approved adoption of Merger Agreement with Texas Instruments (25,878,105 for, 7,467 against).
Silicon Labs annual meeting: directors elected, say-on-pay and equity plan approved
Navdeep Sooch and Nina Richardson elected Class I directors with 26.6M and 26.8M votes for, respectively.
Silicon Labs reports FY 2025 revenue $785M (+34% YoY); GAAP EPS $(1.98); Q4 rev $208M (+25%)
Full-year revenue $785M, up 34% YoY; Industrial & Commercial $445M (+31%), Home & Life $340M (+38%).
Texas Instruments to acquire Silicon Labs for $231 per share in cash
Purchase price of $231.00 per share in cash; total equity value approximately $7.2 billion.
Silicon Labs Q3 revenue $206M, non-GAAP EPS $0.32; guides Q4 rev $200-215M
Revenue $206M; Industrial & Commercial $118M (+22% YoY), Home & Life $88M (+26% YoY).
Silicon Labs Q2 revenue $193M (+33% YoY); guides Q3 $200-210M with non-GAAP EPS $0.20-0.40
Revenue $193M (+33% YoY, +9% QoQ). Industrial & Commercial $110M (+25%), Home & Life $83M (+45%).
Silicon Labs Q1 revenue $178M (+47% YoY); guides Q2 $185-200M with narrowing loss
GAAP operating loss $32M, diluted EPS -$0.94; non-GAAP operating loss $7M, EPS -$0.08.
Silicon Labs annual meeting: all five proposals approved by shareholders
Elected Class III directors Bock, Wyatt, Luther with >95% votes cast in favor.
Audit Committee dismissed Ernst & Young as independent auditor on March 3, 2025, and appointed Deloitte & Touche for fiscal year ending Jan 3, 2026.
Silicon Labs Q4 revenue $166M, nearly doubles YoY; guides Q1 $170-185M
Q4 GAAP diluted EPS loss $(0.73); non-GAAP diluted EPS loss $(0.11).
Silicon Labs Q3 revenue $166M, GAAP EPS $(0.88); guides Q4 revenue $161-171M
Revenue $166M; GAAP operating loss $30M; GAAP diluted loss per share $(0.88).
Silicon Labs Q2 revenue $145M; GAAP EPS loss $(2.56); Q3 guidance $160-170M
GAAP operating loss $48M; GAAP diluted EPS loss $(2.56).
Silicon Labs renews CEO and executive severance agreements through Oct 2027
Compensation Committee approved new CEO Severance Agreement with Matt Johnson and Executive Severance Agreements with Dean Butler, Robert Conrad, Brandon Tolany, Mark Mauldin on July 9, 2024.
Silicon Labs appoints Robert Conrad as SVP Worldwide Operations; Conrad resigns from board
Robert Conrad appointed SVP of Worldwide Operations effective April 29, 2024; he resigns from the Board.
Silicon Labs Q1 revenue $106M, GAAP EPS -$1.77; Q2 outlook $135-145M
Revenue $106M, GAAP gross margin 52%, GAAP operating loss $59M, GAAP diluted EPS $(1.77).
Matt Johnson, Sumit Sadana, and Gregg Lowe elected as Class II directors with over 26M votes each.
As of the Effective Date, Sandeep Kumar will cease serving as Senior Vice President of Worldwide Operations and will serve in a non-executive advisory role.
On April 18, 2024, Robert Conrad notified the Company of his decision to resign from the Company’s Board of Directors effective upon his commencement of employment as Senior Vice President of Worldwide Operations.
On April 24, 2024, Silicon Laboratories Inc. (“Silicon Laboratories” or the “Company”) announced the appointment of Robert Conrad as Senior Vice President of Worldwide Operations, effective April 29, 2024 (the “Effective Date”).
Max materiality 1.00 · Median 0.70 · Most common event earnings